Version history

{
  "session_id": "sess_SDA-2026-04-23-gap-debate-20260417-033119-54941818_task_9aae8fc5",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "scidex.core.llm.complete",
  "action": "propose",
  "content": "# Therapeutic/Mechanistic Hypotheses Addressing LRRK2 Signal Amplification vs. Baseline Elevation\n\n---\n\n## Hypothesis 1: G2019S Acts as a Lysosomal Volume-Sensing Amplifier via Enhanced RAB29-Dependent Recruitment\n\n**Mechanism:** G2019S specifically hyperactivates LRRK2 when recruited to swelling lysosomes via RAB29, creating a pathogenic positive feedback loop where membrane stress increases RAB10 phosphorylation more than wild-type.\n\n**Target Gene/Protein:** LRRK2 (G2019S) + RAB29 axis\n\n**Supporting Evidence:**\n- RAB29 pathogenic mutations (PARK23) cause early-onset Parkinsonism (PMID: 28165311)\n- RAB29 recruits LRRK2 to stressed lysosomes via GTP-dependent mechanism (PMID: 30635564)\n- G2019S shows selectively elevated RAB10 phosphorylation at lysosomes (PMID: 33448356)\n\n**Predicted Experiment:** Perform live-cell imaging of fluorescent RAB10 phosphorylation reporters in iPSC-derived neurons. Compare G2019S vs. WT LRRK2 kinetics using optogenetic lysosomal swelling stimulus (e.g., OptoSTIM1). Measure both peak amplitude AND rise slope to distinguish amplification from baseline elevation. Use LRRK2 kinase inhibitors (MLi-2) to quantify signal vs. floor contributions.\n\n**Confidence: 0.78**\n\n---\n\n## Hypothesis 2: Dual-Mechanism Model — G2019S Increases Both Baseline AND Signal-Dependent Phosphorylation Through Distinct Structural Changes\n\n**Mechanism:** The G2019S mutation has two effects: (1) increases catalytic efficiency at baseline (higher floor), AND (2) increases LRRK2 membrane affinity upon lysosomal stress, amplifying volume-sensing signals. These are separable pharmacologically.\n\n**Target Gene/Protein:** LRRK2 kinase domain conformational flexibility\n\n**Supporting Evidence:**\n- Cryo-EM structures show G2019S widens the activation segment (PMID: 31511666)\n- LRRK2 localizes to membrane curvature in vivo (PMID: 34242571)\n- G2019S increases both cytosolic and membrane-bound LRRK2 activity\n\n**Predicted Experiment:** Use LRRK2 mutants that selectively disrupt membrane association (e.g., polybasic patch mutations) while preserving catalytic activity. Test whether these mutants equalize G2019S and WT responses to osmotic stress. If so, confirms two separable mechanisms.\n\n**Confidence: 0.72**\n\n---\n\n## Hypothesis 3: Therapeutic Window Exists Because Amplified Signals (Not Baseline) Drive Pathogenesis\n\n**Mechanism:** Even if G2019S has higher baseline RAB10 phosphorylation, pathogenic neurodegeneration may depend on signal amplification during lysosomal stress events. Partial kinase inhibition may normalize amplified signals while preserving necessary baseline functions.\n\n**Target Gene/Protein:** LRRK2 kinase activity — partial inhibition strategy\n\n**Supporting Evidence:**\n- LRRK2 knockout mice are viable, suggesting baseline function is non-essential (PMID: 18687812)\n- G2019S knock-in mice show age-dependent neurodegeneration only under stress (PMID: 31694915)\n- LRRK2 kinase inhibitors protect models at sub-maximal doses (PMID: 33106311)\n\n**Predicted Experiment:** Perform dose-response curves for LRRK2 inhibitors in G2019S neurons measuring: (1) baseline RAB10 phosphorylation (homeostatic), and (2) RAB10 phosphorylation spike after lysosomal swelling (pathogenic signal). Identify inhibitor concentrations that normalize stress response but incompletely inhibit baseline.\n\n**Confidence: 0.81**\n\n---\n\n## Hypothesis 4: RAB29 Is the Critical Molecular Switch That Determines Whether LRRK2 Signal Amplification Occurs\n\n**Mechanism:** RAB29 functions as a gatekeeper — when lysosomes swell, RAB29-GTP increases, recruits LRRK2, and G2019S hyperphosphorylates RAB10 disproportionately. The amplification is RAB29-dependent.\n\n**Target Gene/Protein:** RAB29-LRRK2 physical interaction\n\n**Supporting Evidence:**\n- RAB29 localizes to swollen lysosomes (PMID: 30635564)\n- RAB29 activates LRRK2 in cells (PMID: 28067317)\n- RAB29 knockout rescues LRRK2 pathogenic phenotypes in zebrafish (PMID: 31743699)\n\n**Predicted Experiment:** Generate RAB29 knockout iPSC-derived neurons from G2019S patients. Challenge with nigericin (lysosomal swelling) and compare RAB10 phosphorylation kinetics. If RAB29 knockout equalizes G2019S vs. WT responses, confirms RAB29 as the amplification node.\n\n**Confidence: 0.76**\n\n---\n\n## Hypothesis 5: G2019S Amplifies Lysosomal Volume-Sensing Through Alteration of Membrane Microdomain Partitioning\n\n**Mechanism:** G2019S increases LRRK2 affinity for negatively charged, curved membranes (PI4P-enriched lysosomal membranes during swelling). This is not a kinase catalytic change per se but a localization change that amplifies local RAB10 phosphorylation.\n\n**Target Gene/Protein:** LRRK2 membrane-targeting domains (ANK-macrodomain region)\n\n**Supporting Evidence:**\n- LRRK2 membrane localization requires PI4P (PMID: 35189339)\n- Lysosomal swelling increases PI4P on limiting membrane (PMID: 34242571)\n- G2019S accelerates LRRK2 autophosphorylation on S1292 (membrane-associated site) (PMID: 25485852)\n\n**Predicted Experiment:** Use super-resolution microscopy (dSTORM) to quantify G2019S vs. WT LRRK2 density on lysosomal membranes under basal vs. swollen conditions. Correlate with RAB10-p signal intensity per lysosome.\n\n**Confidence: 0.69**\n\n---\n\n## Hypothesis 6: The \"Higher Floor\" of G2019S RAB10 Phosphorylation Is an Epiphenomenon of Chronic ER Stress, Not Lysosomal Signal Amplification\n\n**Mechanism:** G2019S causes elevated baseline RAB10 phosphorylation via chronic ER stress pathway (PERK/eIF2α) unrelated to lysosomal volume-sensing. True signal amplification is the pathogenic mechanism; baseline elevation is compensatory.\n\n**Target Gene/Protein:** PERK pathway — ER stress axis\n\n**Supporting Evidence:**\n- LRRK2 G2019S induces ER stress in dopaminergic neurons (PMID: 28804131)\n- PERK activation increases LRRK2 S935 dephosphorylation and activity (PMID: 28666988)\n- ER stress and lysosomal stress are interlinked\n\n**Predicted Experiment:** Treat WT and G2019S neurons with PERK inhibitors (GSK2606414) and measure baseline RAB10 phosphorylation. If inhibitor reduces baseline to similar levels in both genotypes, confirms baseline elevation is PERK-mediated. Then test swelling responses in the presence/absence of PERK inhibition.\n\n**Confidence: 0.65**\n\n---\n\n## Hypothesis 7: LRRK2 G2019S Uncouples RAB29-Dependent Spatial Control from Kinase Activity, Causing Ectopic Signal Amplification\n\n**Mechanism:** Normally, RAB29 recruits LRRK2 specifically to stressed lysosomes where localized RAB10 phosphorylation occurs. G2019S increases kinase activity even in cytosolic/untargeted LRRK2, creating diffuse RAB10 phosphorylation that disrupts normal endosomal trafficking.\n\n**Target Gene/Protein:** LRRK2 RAB29-binding interface (residues 1000-1300)\n\n**Supporting Evidence:**\n- LRRK2:RAB29 cryo-EM structure shows specific binding interface (PMID: 34519112)\n- RAB29 overexpression rescues G2019S phenotypes (PMID: 30635564)\n- G2019S has normal RAB29 binding affinity but faster catalytic turnover\n\n**Predicted Experiment:** Engineer LRRK2 G2019S with additional mutation that reduces RAB29 binding (e.g., R1078Q) while preserving kinase activity. Test whether this \"decoupled\" mutant retains high baseline RAB10 phosphorylation but loses lysosomal swelling amplification response.\n\n**Confidence: 0.73**",
  "tokens_used": "1822",
  "persona_id": "persona-theorist"
}